Cargando…
Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults
Intanza® 9 μg (Sanofi Pasteur), a trivalent split-virion vaccine administered by intradermal (ID) injection, was approved in Europe in 2009 for the prevention of seasonal influenza in adults 18 to 59 years. Here, we examined the immune responses induced in adults by the ID 9 μg vaccine and the stand...
Autores principales: | Nougarede, Nolwenn, Bisceglia, Hélène, Rozières, Aurore, Goujon, Catherine, Boudet, Florence, Laurent, Philippe, Vanbervliet, Beatrice, Rodet, Karen, Hennino, Ana, Nicolas, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977438/ https://www.ncbi.nlm.nih.gov/pubmed/25483667 http://dx.doi.org/10.4161/hv.29695 |
Ejemplares similares
-
A Meta‐analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events
por: Marra, Fawziah, et al.
Publicado: (2012) -
Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
por: Chotpitayasunondh, Tawee, et al.
Publicado: (2008) -
Long-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adults
por: Song, Joon Young, et al.
Publicado: (2013) -
Immunogenicity and Safety of Reduced-Dose Intradermal vs Intramuscular Influenza Vaccines: A Systematic Review and Meta-analysis
por: Egunsola, Oluwaseun, et al.
Publicado: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)